NCT06674473 Evaluation of Long-term Isokinetic Training of Knee Joint
| NCT ID | NCT06674473 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Peking University Third Hospital |
| Condition | Knee Injuries and Disorders |
| Study Type | INTERVENTIONAL |
| Enrollment | 12 participants |
| Start Date | 2024-11-06 |
| Primary Completion | 2026-10-20 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 12 participants in total. It began in 2024-11-06 with a primary completion date of 2026-10-20.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to assess the effectiveness of isokinetic rehabilitation training under optimal stiffness in patients undergoing knee joint rehabilitation. The main questions it aims to answer are: * Does isokinetic training under optimal stiffness lead to greater force exertion compared to traditional bodyweight training? * What are the long-term (6-week) effects of isokinetic training under optimal stiffness on joint flexibility and muscle strength? Researchers will compare the effects of isokinetic training under optimal stiffness to traditional bodyweight training to see if isokinetic training produces superior improvements in muscle strength, flexibility, and overall functional recovery. Participants will: * Perform regular training sessions using a portable knee joint isokinetic trainer, customized to their optimal stiffness for maximum force exertion. * Engage in a 6-week rehabilitation program, with assessments at the beginning, and end of the study to evaluate changes in muscle strength, and functional recovery.
Eligibility Criteria
Inclusion Criteria: 1. Age between 20-60 years. 2. Patients with unilateral anterior cruciate ligament (ACL) rupture (with or without meniscus injury), posterior cruciate ligament (PCL) rupture, meniscal tear (M), and patellar dislocation (PD). 4\. Postoperative period of 3-6 months. 5. No restriction in knee extension or flexion movements. Exclusion Criteria: 1. Patients with major diseases or conditions such as coronary heart disease, myocardial infarction, heart failure, cerebral infarction, cerebral hemorrhage, or malignant tumors. 2. Pregnant or breastfeeding women and other special populations. 3. Patients who refuse to sign the informed consent form or are unable to complete the entire study process. 4. Patients currently infected with human immunodeficiency virus (HIV), or with a history of infectious hepatitis B or C. 5. Patients with concurrent medical issues, including but not limited to: (1) Uncontrolled hypertension (systolic blood pressure ≥160 mmHg and/or diastolic blood pressure ≥95 mmHg), congestive heart failure (New York Heart Association functional classification of stage III or IV). (2) Patients with mental incapacity or an inability to comprehend the study requirements.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06674473 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, up to 60 Years, studying Knee Injuries and Disorders. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06674473 currently recruiting?
Yes, NCT06674473 is actively recruiting participants. Contact the research team at yanggangfeng@buaa.edu.cn for enrollment information.
Where is the NCT06674473 trial being conducted?
This trial is being conducted at Beijing, China.
Who is sponsoring the NCT06674473 clinical trial?
NCT06674473 is sponsored by Peking University Third Hospital. The trial plans to enroll 12 participants.